31 results on '"van der Hoeven, J.J.M."'
Search Results
2. Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences
3. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
4. Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
5. 1133P Whole genome sequencing can classify diagnostically challenging tumors
6. 2351P Whole genome sequencing of AYA patients
7. Preoperative [18F] FDG–PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology
8. Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry
9. 763P The influence of multidisciplinary team meetings on treatment decisions in muscle invasive bladder cancer: A nationwide study in the Netherlands
10. PCN501 VALUE FOR MONEY IN METASTATIC CUTANEOUS MELANOMA: DO BENEFITS OUTWEIGH THE COSTS OF NOVEL DRUGS?
11. PCN497 A NATIONWIDE COST OF ILLNESS STUDY OF METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS
12. Real-world outcomes of ipilimumab plus nivolumab for advanced melanoma in the Netherlands
13. Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography
14. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study
15. Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population
16. Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
17. 1353P - Real-world outcomes of ipilimumab plus nivolumab for advanced melanoma in the Netherlands
18. Everolimus in patients with advanced follicular-derived thyroid cancer; results of a phase II clinical trial.
19. Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism
20. 1276P - Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population
21. 187O - High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study
22. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
23. Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
24. Re: Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern
25. Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer
26. Bepridil in combination with anthracyclines in the attempt to reverse anthracycline-resistance in cancer patients
27. Qualitative and quantitative kinetics of submucosally administered antibody fragments in patients with rectal carcinoma: the detection of lymph node metastasis in relation to local tracer diffusion
28. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein supplement
29. Staging in patients with locoregionally recurrent breast cancer: current practice and perspectives for PET
30. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: Role of protein binding
31. Response monitoring in advanced breast cancer using positron emission tomography methodological aspects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.